Table 1: Short-term effects of anti-TNF drugs on atherogenic index and other ratios.

StudyDrugNumber of patientsDurationEffect
AIOther ratios

Popa et al. [24]ADA332 wkLLDL : HDL
Wijbrandts et al. [32]ADA5016 wkLapoB : apoA-1
Gonzalez-Juanatey et al. [45]ADA812 wkL
Kume et al. [21]ADA/ETN4224 wkn
Seriolo et al. [26]ADA/ETN/IFX3424 wkn
Soubrier et al. [28]ADA/ETN/IFX2914 wknapoB : apoA-1
Jamnitski et al. [19]ETN29216 wkLapoB : apoA-1
Allanore et al. [15]IFX5630 wknLDL : HDL
Popa et al. [11]IFX4524 wkH
Dahlqvist et al. [17]IFX5224 wkH
Popa et al. [25]IFX5524 wkH
Tam et al. [30]IFX1914 wknLDL : HDL
Vis et al. [31]IFX696 wkn
Engvall et al. [18]IFX4014 wkapoB : apoA-1
Ajeganova et al. [14]ADA/ETN/IFX16224 wkapoB : apoA-1
Curtis et al. [16]not specified2898 wkL

ETN: etanercept, ADA: adalimumab, IFX: infliximab, AI: atherogenic index, wk: weeks, L: lower, n: neutral, H: higher.